Ranitidine Recalls Begin In Europe As Regulators Take Action
Executive Summary
OTC products are among the first to be recalled in Europe following the discovery of a human carcinogen in ranitidine-based drugs.With investigations underway worldwide, regulators across Europe are split into two camps: immediate action or wait and see.
You may also be interested in...
EMA Stands By Suspension Of Ranitidine
Suspension of heartburn remedy ranitidine looming in the EU as the European Medicines Agency stands by its original decision.
EMA Stands By Suspension Of Ranitidine In EU After Re-Examination
Suspension of heartburn remedy ranitidine looming in the EU as the European Medicines Agency stands by its original decision.
EMA Advocates Suspension Of All Ranitidine Drugs In EU
Concerns over the presence of a probable human carcinogen will likely see marketing of all ranitidine-containing drugs suspended across the European Union.